You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Acute Myeloid Leukaemia

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Acute Myeloid Leukemia, MDS Trial (idarubicin, Cytarabine)

Not yet recruiting
  • Acute Myeloid Leukemia
  • Myelodysplastic Syndromes
  • (no location specified)
Sep 18, 2023

Acute Myeloid Leukaemia Trial in Worldwide (S 64315 (also referred as MIK665) and azacitidine)

Active, not recruiting
  • Acute Myeloid Leukaemia
  • S 64315 (also referred as MIK665) and azacitidine
  • Houston, Texas
  • +6 more
Dec 16, 2022

Acute Myeloid Leukaemia Trial in Australia, France, United States (S 64315 (also referred as MIK665) and venetoclax)

Terminated
  • Acute Myeloid Leukaemia
  • S 64315 (also referred as MIK665) and venetoclax
  • New Haven, Connecticut
  • +6 more
Dec 20, 2022

Relapsed Acute Myeloid Leukaemia Trial (Cryopreserved BE CAR33 T Cells (BE752TBTTBCAR33PBL))

Not yet recruiting
  • Relapsed Acute Myeloid Leukaemia
  • Cryopreserved BE CAR33 T Cells (BE752TBTTBCAR33PBL)
  • (no location specified)
Jul 4, 2023

Acute Myeloid Leukemia Trial (TCB008)

Recruiting
  • Acute Myeloid Leukemia
  • Bristol, United Kingdom
  • +5 more
Jan 10, 2023

Acute Myeloid Leukemia in Remission Trial in Worldwide (DCP-001)

Active, not recruiting
  • Acute Myeloid Leukemia in Remission
  • DCP-001
  • Helsinki, Finland
  • +9 more
Oct 7, 2022

Acute Myeloid Leukaemia Trial (SAR445419, fludarabine, cytarabine)

Not yet recruiting
  • Acute Myeloid Leukaemia
  • (no location specified)
Feb 2, 2023

Cancer, MDS-EB, MDS Trial in Athens, Southampton, Sheffield (INKmune)

Recruiting
  • Cancer
  • +4 more
  • INKmune
  • Athens, Attiki, Greece
  • +2 more
Jul 3, 2023

Acute Myeloid Leukaemia (AML), Myelodysplastic Syndrome (MDS) Trial in Worldwide (S64315 once a week, S64315 twice a week)

Completed
  • Acute Myeloid Leukaemia (AML)
  • Myelodysplastic Syndrome (MDS)
  • S64315 once a week
  • S64315 twice a week
  • New Haven, Connecticut
  • +8 more
May 17, 2022

MDS, Chronic Myelomonocytic Leukemia, Acute Myeloid Leukemia Trial in Sydney (Decitabine/Cedazuridine 35 Mg-100 Mg ORAL TABLET,

Recruiting
  • Myelodysplastic Syndromes
  • +2 more
  • Decitabine/Cedazuridine 35 Mg-100 Mg ORAL TABLET
  • Defactinib
  • Sydney, New South Wales, Australia
  • +3 more
Jan 12, 2023

Acute Myeloid Leukaemia (AML), Myelodysplastic Syndrome (MDS), Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) Trial

Not yet recruiting
  • Acute Myeloid Leukaemia (AML)
  • +2 more
  • (no location specified)
Sep 6, 2022

Real World Outcomes Using Novel Agents for AML in the UK

Not yet recruiting
  • Acute Myeloid Leukemia
  • London, United Kingdom
    Guy's and St Thomas' NHS Foundation Trust
Mar 28, 2022

Acute Myeloid Leukaemia Trial in Australia, United States (AZD2811, Azacitidine, Venetoclax)

Terminated
  • Acute Myeloid Leukaemia
  • Denver, Colorado
  • +10 more
Mar 24, 2022

Acute Myeloid Leukaemia, Myelodysplasia Trial in Birmingham (Vyxeos, Fludarabine, Busulphan)

Recruiting
  • Acute Myeloid Leukaemia
  • Myelodysplasia
  • Birmingham, United Kingdom
    Queen Elizabeth Hospital
Oct 14, 2021

Acute Myeloid Leukemia (AML) Trial in Nantes (Siltuximab)

Not yet recruiting
  • Acute Myeloid Leukemia (AML)
  • Nantes, France
    CHU de Nantes
Jan 24, 2023

Acute Lymphocytic Leukaemia; Acute Myeloid Leukaemia Refractory; Myelodysplastic Syndrome Trial in Australia, Netherlands,

Recruiting
  • Acute Lymphocytic Leukaemia; Acute Myeloid Leukaemia Refractory; Myelodysplastic Syndrome
  • Duarte, California
  • +12 more
Jan 4, 2023

Acute Myeloid Leukaemia; MDS;Chronic Myelomonocytic Leukemia Trial in Shenzhen (Azacytidine, HAG Regimen, Azacytidine)

Recruiting
  • Acute Myeloid Leukaemia; Myelodysplastic Syndromes;Chronic Myelomonocytic Leukemia
  • Shenzhen, Guangdong, China
    Shenzhen Second People's Hospital
Mar 14, 2022

AML, Adult Trial in Netherlands (azacitidine, Venetoclax, Cobicistat)

Not yet recruiting
  • AML, Adult
  • Amersfoort, Netherlands
  • +17 more
Aug 23, 2023

Tumors Trial in Canada, United States (GSK3326595, 5-Azacitidine)

Terminated
  • Neoplasms
  • Birmingham, Alabama
  • +7 more
Feb 10, 2022

Acute Myeloid Leukemia Trial in Praha (OmnImmune®)

Completed
  • Acute Myeloid Leukemia
  • OmnImmune®
  • Praha, Czechia
    UHKT (Ustav hematologie a krevni transfuze)
Mar 29, 2021

Acute Myeloid Leukemia Trial in Spain (OPB-111077)

Completed
  • Acute Myeloid Leukemia
  • Cáceres, Extremadura, Spain
  • +5 more
Feb 10, 2021

Acute Biphenotypic Leukemia, Acute Erythroid Leukemia in Remission, Acute Leukemia in Remission Trial in Seattle (drug,

Terminated
Has Results
  • Acute Biphenotypic Leukemia
  • +29 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Jan 4, 2023

Relapsed/Refractory Acute Myeloid Leukaemia, Myeloid Malignancy Trial in China (APG-2575, reduced-dose HHT, standard-dose HHT)

Recruiting
  • Relapsed/Refractory Acute Myeloid Leukaemia
  • Myeloid Malignancy
  • Beijing, Beijing, China
  • +9 more
Jan 10, 2022

Hodgkin's Lymphoma, Non-Hodgkin's Lymphoma, Acute Myeloid Leukaemia Trial in United Kingdom (Reduced intensity haplodentical

Active, not recruiting
  • Hodgkin's Lymphoma
  • +8 more
  • Reduced intensity haplodentical stem cell transplant
  • Myeloablative haploidentical stem cell transplant
  • Birmingham, United Kingdom
  • +11 more
Sep 27, 2021

Acute Myeloid Leukemia, Myelodysplasia Trial in United Kingdom (Oral azacitidine, Matched )

Recruiting
  • Acute Myeloid Leukemia
  • Myelodysplasia
  • Oral azacitidine
  • Matched placebo
  • Birmingham, United Kingdom
  • +20 more
Oct 14, 2021